Search filters

List of works by Gebra Cuyun Carter

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer

scientific article

An exploratory subgroup analysis of race and gender in squamous cancer of the head and neck: inferior outcomes for African American males in the LORHAN database

scientific article published on 14 March 2014

Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer

scientific article published on 02 March 2019

Comprehensive review of factors implicated in the heterogeneity of response in depression ⬇️

scientific article published on April 1, 2012

Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration

scientific article published in 2021

Dietary Intake, Food Processing, and Cooking Methods Among Amish and Non-Amish Adults Living in Ohio Appalachia: Relevance to Nutritional Risk Factors for Cancer ⬇️

scientific article published on October 25, 2011

Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial

scientific article published on 21 December 2017

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy

scientific article published on 01 January 2020

Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review

scientific article published on 27 July 2015

Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy

scientific article published on 24 October 2019

Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis ⬇️

scientific article published on August 6, 2013

KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis

scientific article published on 25 July 2020

KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis

scientific article

Metastatic colorectal cancer treatment patterns according to kirsten rat sarcoma viral oncogene homolog genotype in U.S. Community-based oncology practices

scientific article published on 23 June 2014

Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative

scientific article

Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer.

scientific article published on 5 August 2017

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States

scientific article published on 22 June 2020

Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy

scientific article

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea

scientific article published on 12 September 2016

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol.

scientific article

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2- advanced breast cancer in five European countries

scientific article published on 07 September 2020

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1

scientific article published on 12 August 2020

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

scientific article published on 15 April 2019

Review of treatment response in rheumatoid arthritis: assessment of heterogeneity

scientific article published on 27 January 2011

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study ⬇️

scientific article published on August 26, 2011

The Budget Impact of Including Necitumumab on the Formulary for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer: U.S. Commercial Payer and Medicare Perspectives.

scientific article published in June 2018

The Use of Daily Aspirin, Nutritional Supplements and Alternative Medications among Amish and non-Amish living in Ohio Appalachia ⬇️

scientific article published on October 4, 2012

Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer.

scientific article published on 3 June 2017

Treatment patterns in patients with advanced gastric cancer in Taiwan

scientific article published on 25 April 2016

Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United States

scientific article published on 05 August 2020

Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer

scientific article published on 12 June 2019

Paulina is supported by:

About Paulina

Help